Wegovy is administered once weekly on the same day each week through subcutaneous injection into the thigh, abdomen, or upper arm, with sites rotated to prevent skin irritation. Proper injection ...
Alkem Laboratories Share Price | The company launched semaglutide pre-filled disposable injection pen at a price starting Rs 1,800 for a month’s dosage. Alkem Laboratories share price down marginally ...
The Tribune, now published from Chandigarh, started publication on February 2, 1881, in Lahore (now in Pakistan). It was started by Sardar Dyal Singh Majithia, a public-spirited philanthropist, and is ...
I’ll be honest, despite being a nutritional therapist, I’m not a supplement junkie. So why did I decide to try the buzzy NAD+ injection pen when I favour a food-first approach and lifestyle tweaks ...
Researchers have explored human preferences for robot motion on a variety of household tasks. The study aimed to investigate whether preferences were similar between tasks, users, and if robots should ...
BusinessWire India Ahmedabad (Gujarat) [India], March 21: Zydus Lifesciences Limited (including its subsidiaries, hereafter referred to as "Zydus"), an innovation-led global lifesciences company, has ...
March 23 (Reuters) - At least half a dozen Indian generic drugmakers launched cheaper versions of Novo Nordisk's (NOVOb.CO), opens new tab blockbuster diabetes drug Ozempic and weight‑loss drug Wegovy ...
Swati Pradhan sees about 12 obesity patients a day at her small clinic in southern Mumbai. She expects this number to at least double from this month as Indian drug makers prepare to launch off-patent ...
The TrumpRx website claims to offer the best prices for medications. Here’s where Americans still pay more — and much more. By Rebecca Robbins Rebecca Robbins covers the pharmaceutical industry. She ...
The upcoming expiry of the semaglutide patent in India in mid-March 2026 is expected to transform the country's diabetes treatment landscape. Ahead of this, industry experts predict that the ...
Starting today, eligible customers can access a broad assortment of treatment options, including the only FDA-approved GLP-1 weight loss pill Based on an independent provider’s clinical decision, ...
Hosted on MSN
Alkem Laboratories launches semaglutide in India at Rs 450 per week, eyes booming weight-loss market
Alkem Laboratories on Saturday said it has launched semaglutide injection in India, entering the fast-growing market for diabetes and weight loss drug with a product priced at a starting weekly cost ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results